InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Kies Peter, Chief Financial Officer. Director active across 2 companies, notably INOVIO PHARMACEUTICALS, INC.. Aggregated, 12 reports have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €66k. Activity tracked since 3 June 2021. The latest transaction was disclosed on 9 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kies Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
5,010 sharesCommon StockSEC:0001259780-26-000002:0
4,771 sharesCommon StockSEC:0001055726-25-000029:0
3,997 sharesCommon StockSEC:0001055726-25-000002:0
4,771 sharesCommon StockSEC:0001055726-24-000031:0
1,878 sharesCommon StockSEC:0001055726-24-000003:0
59,737 sharesCommon StockSEC:0001055726-23-000011:0
22,544 sharesCommon StockSEC:0001055726-23-000005:0
59,737 sharesCommon StockSEC:0001055726-22-000019:0
21,466 sharesCommon StockSEC:0001055726-22-000017:0
22,545 sharesCommon StockSEC:0001055726-22-000012:0
13,750 shares@ US$2.1626.9% of flowCommon StockSEC:0001055726-21-000050:0
10,000 shares@ US$8.0373.1% of flowCommon StockSEC:0001055726-21-000049:0
12 of 12 declarations
About Kies Peter
KIES PETER is Directeur Financier at INOVIO PHARMACEUTICALS, INC. and Inovio Pharmaceuticals, INC. The record shows 12 filings in total, and among the recent filings sampled, the period runs from 2021-06-04 to 2026-02-27, with 0 in buys and 66183 in sells, and the most common transaction nature being Levée d'options.
